NEW YORK--(BUSINESS WIRE)--ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), announced today that the Company will host an analyst and institutional investor meeting on Thursday, June 23, 2011, from 5:00 to 6:30 PM Eastern Time in New York City. The event will be moderated by Jonathan Lewis, MD, PhD, Chief Executive Officer of ZIOPHARM, and will be comprised of an in-depth panel discussion of the Company’s synthetic biology and small molecule development programs.
